BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36920409)

  • 1. Association between GPC2 polymorphisms and neuroblastoma risk in Chinese children.
    Li M; Zhang X; Liu J; Zhou C; Miao L; He J; Wu H; Zhang R
    J Clin Lab Anal; 2023 Mar; 37(5):e24866. PubMed ID: 36920409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutically targeting glypican-2 via single-domain antibody-based chimeric antigen receptors and immunotoxins in neuroblastoma.
    Li N; Fu H; Hewitt SM; Dimitrov DS; Ho M
    Proc Natl Acad Sci U S A; 2017 Aug; 114(32):E6623-E6631. PubMed ID: 28739923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIR938 rs2505901 T>C polymorphism is associated with increased neuroblastoma risk in Chinese children.
    Jiang S; Sun X; Zhang X; Zhou C; Wu H; He J; Yang W
    Biosci Rep; 2023 Nov; 43(11):. PubMed ID: 37905791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma.
    Bosse KR; Raman P; Zhu Z; Lane M; Martinez D; Heitzeneder S; Rathi KS; Kendsersky NM; Randall M; Donovan L; Morrissy S; Sussman RT; Zhelev DV; Feng Y; Wang Y; Hwang J; Lopez G; Harenza JL; Wei JS; Pawel B; Bhatti T; Santi M; Ganguly A; Khan J; Marra MA; Taylor MD; Dimitrov DS; Mackall CL; Maris JM
    Cancer Cell; 2017 Sep; 32(3):295-309.e12. PubMed ID: 28898695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors.
    Foster JB; Griffin C; Rokita JL; Stern A; Brimley C; Rathi K; Lane MV; Buongervino SN; Smith T; Madsen PJ; Martinez D; Delaidelli A; Sorensen PH; Wechsler-Reya RJ; Karikó K; Storm PB; Barrett DM; Resnick AC; Maris JM; Bosse KR
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36167467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LIN28A gene polymorphisms modify neuroblastoma susceptibility: A four-centre case-control study.
    Hua RX; Zhuo Z; Ge L; Zhu J; Yuan L; Chen C; Liu J; Cheng J; Zhou H; Zhang J; Xia H; Zhang X; He J
    J Cell Mol Med; 2020 Jan; 24(1):1059-1066. PubMed ID: 31747721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RTEL1 gene polymorphisms and neuroblastoma risk in Chinese children.
    Zhang T; Zhou C; Guo J; Chang J; Wu H; He J
    BMC Cancer; 2023 Nov; 23(1):1145. PubMed ID: 38001404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association between GWAS-identified BARD1 Gene SNPs and Neuroblastoma Susceptibility in a Southern Chinese Population.
    Zhang R; Zou Y; Zhu J; Zeng X; Yang T; Wang F; He J; Xia H
    Int J Med Sci; 2016; 13(2):133-8. PubMed ID: 26941572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TP53 Arg72Pro polymorphism and neuroblastoma susceptibility in eastern Chinese children: a three-center case-control study.
    Fang Y; Wu X; Li L; Zhu J; Wu H; Zhou H; He J; Wang Y
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32406493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HOTAIR gene polymorphisms contribute to increased neuroblastoma susceptibility in Chinese children.
    Yang X; He J; Chang Y; Luo A; Luo A; Zhang J; Zhang R; Xia H; Xu L
    Cancer; 2018 Jun; 124(12):2599-2606. PubMed ID: 29603181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between
    Hu C; Yang T; Pan J; Zhang J; Yang J; He J; Zou Y
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30890582
    [No Abstract]   [Full Text] [Related]  

  • 12. GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity.
    Heitzeneder S; Bosse KR; Zhu Z; Zhelev D; Majzner RG; Radosevich MT; Dhingra S; Sotillo E; Buongervino S; Pascual-Pasto G; Garrigan E; Xu P; Huang J; Salzer B; Delaidelli A; Raman S; Cui H; Martinez B; Bornheimer SJ; Sahaf B; Alag A; Fetahu IS; Hasselblatt M; Parker KR; Anbunathan H; Hwang J; Huang M; Sakamoto K; Lacayo NJ; Klysz DD; Theruvath J; Vilches-Moure JG; Satpathy AT; Chang HY; Lehner M; Taschner-Mandl S; Julien JP; Sorensen PH; Dimitrov DS; Maris JM; Mackall CL
    Cancer Cell; 2022 Jan; 40(1):53-69.e9. PubMed ID: 34971569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The rs2147578 C > G polymorphism in the Inc-LAMC2-1:1 gene is associated with increased neuroblastoma risk in the Henan children.
    Yang T; Zhang Z; Zhang J; Tan T; Yang J; Pan J; Hu C; Li J; Xia H; He J; Zou Y
    BMC Cancer; 2018 Oct; 18(1):948. PubMed ID: 30285664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NSUN2 gene rs13181449 C>T polymorphism reduces neuroblastoma risk.
    Lin L; Deng C; Zhou C; Zhang X; Zhu J; Liu J; Wu H; He J
    Gene; 2023 Feb; 854():147120. PubMed ID: 36529349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-100 rs1834306 a > G polymorphism decreases neuroblastoma risk in Chinese children.
    Han Y; Chang J; Lin L; Zhou C; Zhu J; Wu H; He J; Fu W
    Cancer Rep (Hoboken); 2023 Oct; 6(10):e1875. PubMed ID: 37503828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of MYC gene polymorphisms with neuroblastoma risk in Chinese children: A four-center case-control study.
    Pan J; Zhu J; Wang M; Yang T; Hu C; Yang J; Zhang J; Cheng J; Zhou H; Xia H; He J; Zou Y
    J Gene Med; 2020 Aug; 22(8):e3190. PubMed ID: 32222109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of GWAS-identified SNPs at 6p22 with neuroblastoma susceptibility in a Chinese population.
    He J; Zhang R; Zou Y; Zhu J; Yang T; Wang F; Xia H
    Tumour Biol; 2016 Feb; 37(2):1635-9. PubMed ID: 26307394
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Zhang J; Zhuo Z; Li W; Zhu J; He J; Su J
    Aging (Albany NY); 2018 Oct; 10(10):2944-2953. PubMed ID: 30362960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentially functional polymorphisms in the LIN28B gene contribute to neuroblastoma susceptibility in Chinese children.
    He J; Yang T; Zhang R; Zhu J; Wang F; Zou Y; Xia H
    J Cell Mol Med; 2016 Aug; 20(8):1534-41. PubMed ID: 27021521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A GPC2 antibody-drug conjugate is efficacious against neuroblastoma and small-cell lung cancer via binding a conformational epitope.
    Raman S; Buongervino SN; Lane MV; Zhelev DV; Zhu Z; Cui H; Martinez B; Martinez D; Wang Y; Upton K; Patel K; Rathi KS; Navia CT; Harmon DB; Li Y; Pawel B; Dimitrov DS; Maris JM; Julien JP; Bosse KR
    Cell Rep Med; 2021 Jul; 2(7):100344. PubMed ID: 34337560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.